Bhutan BFDA Medical Device Registration: Full vs Abridged ACTD Pathway

Quick answer

Medical devices marketed in Bhutan require Marketing Authorization (MA) from the Medical Product Division (MPD) of the Bhutan Food and Drug Authority (BFDA) under the Medicines Act of the Kingdom of Bhutan 2003 and the Guideline for Registration of Medical Devices, 2022. Applicants submit dossiers in ASEAN Common Technical Dossier (ACTD) format through BFDA's online submission forms. Two initial registration routes exist: Full registration (complete ACTD dossier for any registrable device) and Abridged registration (AR) for eligible devices with reference-authority approval or WHO prequalification per the guideline. After format check and fee payment, dossiers pass Pre-Screening, then Technical Evaluation (TE); MA certificates issue in hard copy after certificate fee payment. Renewal, Post Approval Variation (PAV), and Import Authorization follow separate online workflows tied to the same 2022 guideline.

Who this applies to

This guide applies to:

• Foreign manufacturers exporting Class B, C, and D medical devices to Bhutan
• Local importers and distributors holding or seeking BFDA marketing authorization
• Regulatory affairs teams mapping ASEAN ACTD/CSDT experience to Bhutan's MPD portal
• Quality and RA consultants supporting renewal, variation, or import authorization after initial MA

Device scope covers medical devices regulated by MPD, including in vitro diagnostics where classified under the 2022 guideline. Class A low-risk devices are generally exempt from registration under Bhutan's risk-based classification aligned with GHTF/IMDRF principles—confirm your device class against the current BFDA class lists before assuming exemption.

Regulatory framework: BFDA MPD and the 2022 Guideline

The Medical Product Division (MPD) regulates medical products—medicines, vaccines, blood products, traditional medicines, health supplements, and medical devices—under the Medicines Act of the Kingdom of Bhutan 2003. MPD's mandate includes registering imported and domestically manufactured products, inspecting sale and storage premises, and maintaining post-market surveillance.

For medical devices specifically, BFDA publishes procedural steps on its MPD services page at bfda.gov.bt/medical-product-division/. Initial registration, renewal, variation, and import authorization all reference the Guideline for Registration of Medical Devices, 2022. Dossiers must follow ACTD format as prescribed by the authority—the same modular structure familiar from ASEAN harmonization (administrative data, summaries, quality, nonclinical, clinical modules as applicable by class).

BFDA also maintains public lists of Marketing Authorized medical devices, cancelled and withdrawn MA, and authorized premises—useful for predicate research and distributor due diligence.

Note on guideline updates: BFDA opened public consultation on a revised Guideline for Registration of Medical Devices in 2026. The 2022 guideline remains the operative reference on the MPD services page at the time of writing. Verify the current published version before submission.

Full registration vs abridged registration (AR): which pathway?

Bhutan offers two distinct initial MA routes for medical devices. Choosing correctly affects dossier depth, review time, and evidence expectations.

The abridged route is typically the fastest path for manufacturers holding approvals from stringent or recognized authorities named in the 2022 guideline. The full route remains mandatory when AR eligibility criteria are not met—for example, devices without a qualifying reference MA or outside WHO prequalification scope.

Do not conflate Bhutan's AR (Abridged Registration) with pharmaceutical ER (Expedited Registration) or CR (Company Recognition) routes on the medicines side; those pharmaceutical-specific pathways do not apply to the medical device submission forms listed on the MPD page.

ACTD dossier structure for Bhutan

Although BFDA's public MPD page emphasizes ACTD format rather than publishing the full module checklist online, the 2022 guideline defines required sections by device class. Plan your dossier around standard ACTD modules:

1. Module 1 — Administrative and prescribing information: Application form, cover letter, product information, labeling, certificates of free sale, GMP/ISO evidence, power of attorney, device classification rationale.
2. Module 2 — Summaries: Executive summary, device description, intended use, essential principles checklist.
3. Module 3 — Quality: Manufacturing information, sterilization, stability, biocompatibility references as applicable.
4. Module 4 — Nonclinical data: Bench testing, animal studies where required by class.
5. Module 5 — Clinical evidence: Clinical evaluation report, literature, or clinical investigation data for higher-risk classes.

For AR dossiers, the guideline specifies which modules may be abbreviated or replaced by reference to the approved dossier in the reference jurisdiction. Include the reference MA certificate, approval letter, and summary technical documentation from the recognized authority as cross-references—not as substitutes for Bhutan-specific labeling and administrative modules.

Step-by-step marketing authorization workflow

The BFDA MPD page describes the following sequence for both Full and AR initial registrations:

Step 1 — Select the correct online submission form

• Full route: Submit the duly filled Application for Full registration of medical devices with relevant documents per Guideline 2022 in ACTD format via the Full dossier submission form for Medical device.
• AR route: Submit the Application for Abridge registration of medical devices with relevant documents per Guideline 2022 via the AR dossier submission form for medical devices.

Use the dedicated device links on the MPD page—not the pharmaceutical full/ER/AR links, which reference the Guideline for registration of medicinal products 2020.

Step 2 — Format check, samples, and application fees

After submission, the Authority checks dossier format. If the dossier meets format requirements, BFDA communicates via the registered email address to request product samples (where applicable) and payment of application fees. Respond promptly; delayed fee payment stalls the evaluation queue.

Step 3 — Pre-Screening

The dossier undergoes Pre-Screening. MPD evaluates format compliance and completeness—missing or misfiled documents trigger email communication to the applicant. Submit corrections through the Pre-screened missing documents submission link on the MPD portal.

Pre-Screening is administrative and completeness-focused. It does not substitute for substantive technical review but blocks progression until discrepancies are resolved.

Step 4 — Technical Evaluation (TE)

After Pre-Screening discrepancies are addressed, the Authority plans the dossier for Technical Evaluation. TE assesses quality, safety, and performance evidence against Guideline 2022 requirements and Bhutan classification.

Queries arising during TE are communicated by email. Applicants respond via the Technical Evaluation missing documents submission link. Unlike pharmaceutical products evaluated under a published monthly Dossier Evaluation Plan, the device workflow explicitly separates Pre-Screening from TE with dedicated resubmission channels—track which link BFDA cites in each query letter.

Step 5 — Marketing Authorization certificate issuance

Following successful TE and any required sample testing, the Marketing Authorization certificate is issued in hard copy after payment of certificate fees. Plan for physical certificate logistics if your Bhutan importer requires the original for customs or Technical Authorization purposes.

Renewal of marketing authorization

Registered devices require periodic renewal per Guideline 2022 validity periods. The renewal workflow on the MPD page:

1. Submit the Application for renewal of medical device registration with relevant documents per Guideline 2022 via the Renewal dossier submission form for medical devices.
2. MPD evaluates the renewal dossier.
3. Outcome (Approved, Query, or Rejected) is communicated via registered email.
4. Applicants submit missing documents via the Missing documents submission link.
5. Renewed MA certificate issues in hard copy after certificate fee payment.

Renewal dossiers typically require updated GMP/ISO certificates, post-market surveillance summaries, and confirmation that no unauthorized changes occurred since last MA. Material changes since last approval may require PAV before or alongside renewal—do not bundle undisclosed design or labeling changes into a routine renewal without assessing variation requirements.

Post Approval Variations (PAV)

Changes to approved device attributes—manufacturer site, labeling, intended use, software version, sterilization method, or supplier of critical components—generally require **Post Approval Variation (PA...